Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the Democratic Republic of the Congo and Uganda.

Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the Democratic Republic of the Congo and Uganda.

The outbreak is only the third caused by the rare Bundibugyo virus, for which there are no approved vaccines or therapeutics.